Evercore Partners Inc (NYSE:EVR) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an EPS of $3.41 against a forecast of $3.04. The company also exceeded revenue ...

Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

KBW analyst Aidan Hall reiterated a Buy rating on Evercore Partners (EVR – Research Report) today and set a price target of $339.00. The ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Reports Q4 adjusted revenue $980.5M, consensus $883.4M. John Weinberg, Chairman and Chief Executive Officer, “We are pleased with our ...

Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...

Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business,based in New York. “We are ...

Good morning, and welcome to the Evercore Fourth Quarter 2024 and Full-Year Earnings Conference Call. Today's call is scheduled to last about 1 hour, including remarks by Evercore management and ...